AstraZeneca’s £450 million vaccine plant at risk as government reconsiders financial backing
The US Treasury has confirmed it remains in "positive discussions" with AstraZeneca over the pharmaceutical giant's proposed £450m vaccine manufacturing facility in northwest England.
However, doubts have emerged following reports…